A simple method for measuring red cell deformability in models of the microcirculation.

PubWeight™: 1.75‹?› | Rank: Top 3%

🔗 View Article (PMID 4715117)

Published in Blut on June 01, 1973

Authors

H Schmid-Schönbein, J Weiss, H Ludwig

Articles by these authors

(truncated to the top 100)

International uniform response criteria for multiple myeloma. Leukemia (2006) 17.78

Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma. J Clin Oncol (2000) 9.70

Purification and characterization of a potent bactericidal and membrane active protein from the granules of human polymorphonuclear leukocytes. J Biol Chem (1978) 4.61

International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders. Leukemia (2008) 3.41

Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management. Leukemia (2010) 3.31

Separation and purification of a potent bactericidal/permeability-increasing protein and a closely associated phospholipase A2 from rabbit polymorphonuclear leukocytes. Observations on their relationship. J Biol Chem (1979) 3.15

Resistance of gram-negative bacteria to purified bactericidal leukocyte proteins: relation to binding and bacterial lipopolysaccharide structure. J Clin Invest (1980) 2.99

Borna disease: a persistent virus infection of the central nervous system. Prog Med Virol (1988) 2.83

Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma. Leukemia (2007) 2.76

Genomic organization of Borna disease virus. Proc Natl Acad Sci U S A (1994) 2.74

The decision to breastfeed in the United States: does race matter? Pediatrics (2001) 2.67

Intracellular Ca(2+) dynamics and the stability of ventricular tachycardia. Biophys J (1999) 2.65

Seizure-associated brain injury in term newborns with perinatal asphyxia. Neurology (2002) 2.49

Borna disease virus, a negative-strand RNA virus, transcribes in the nucleus of infected cells. Proc Natl Acad Sci U S A (1992) 2.44

Repetitive sequences in complete and defective genomes of Herpesvirus saimiri. J Virol (1975) 2.36

A reevaluation of the roles of the O2-dependent and O2-independent microbicidal systems of phagocytes. Rev Infect Dis (1983) 2.35

Race, family income, and low birth weight. Am J Epidemiol (1991) 2.30

Borna disease virus genome transcribed and expressed in psychiatric patients. Nat Med (1995) 2.30

The red cell as a fluid droplet: tank tread-like motion of the human erythrocyte membrane in shear flow. Science (1978) 2.29

Cimetidine, cigarette smoking, and recurrence of duodenal ulcer. N Engl J Med (1984) 2.29

Cloning of the cDNA of a human neutrophil bactericidal protein. Structural and functional correlations. J Biol Chem (1989) 2.29

The challenge of biosimilars. Ann Oncol (2007) 2.28

The prognostic significance of proliferating cell nuclear antigen, epidermal growth factor receptor, and mdr gene expression in colorectal cancer. Cancer (1993) 2.23

Recent skin self-examination and doctor visits in relation to melanoma risk and tumour depth. Br J Dermatol (2012) 2.20

High-affinity binding of the bactericidal/permeability-increasing protein and a recombinant amino-terminal fragment to the lipid A region of lipopolysaccharide. Infect Immun (1992) 2.17

Identification of a common antigen of herpes simplex virus bovine herpes mammillitis virus, and B virus. J Virol (1978) 2.16

Interleukin-6 is a prognostic factor in multiple myeloma. Blood (1991) 2.16

Partial characterization and purification of a rabbit granulocyte factor that increases permeability of Escherichia coli. J Clin Invest (1975) 2.16

A nanogram dose of the CYP3A probe substrate midazolam to evaluate drug interactions. Clin Pharmacol Ther (2013) 2.15

Transmyocardial laser revascularisation compared with continued medical therapy for treatment of refractory angina pectoris: a prospective randomised trial. ATLANTIC Investigators. Angina Treatments-Lasers and Normal Therapies in Comparison. Lancet (1999) 2.14

Diurnal pattern of QTc interval: how long is prolonged? Possible relation to circadian triggers of cardiovascular events. J Am Coll Cardiol (1996) 2.09

A viro-psycho-immunological disease-model of a subtype affective disorder. Pharmacopsychiatry (1998) 2.08

Functional compartmentation of glycolytic versus oxidative metabolism in isolated rabbit heart. J Clin Invest (1985) 2.05

Killing of gram-negative bacteria by polymorphonuclear leukocytes: role of an O2-independent bactericidal system. J Clin Invest (1982) 2.04

An evolving view of Saturn's dynamic rings. Science (2010) 1.99

Latex sensitization in health care workers and in the US general population. Am J Epidemiol (2001) 1.98

Estrogen receptor binding to DNA is not required for its activity through the nonclassical AP1 pathway. J Biol Chem (2001) 1.98

Role of charge and hydrophobic interactions in the action of the bactericidal/permeability-increasing protein of neutrophils on gram-negative bacteria. J Clin Invest (1983) 1.93

Presence of a p53 gene deletion in patients with multiple myeloma predicts for short survival after conventional-dose chemotherapy. Blood (1998) 1.90

Physicochemical properties of the DNA of herpes viruses. Biochim Biophys Acta (1972) 1.86

Nonclassical estrogen receptor alpha signaling mediates negative feedback in the female mouse reproductive axis. Proc Natl Acad Sci U S A (2007) 1.86

A 25-kDa NH2-terminal fragment carries all the antibacterial activities of the human neutrophil 60-kDa bactericidal/permeability-increasing protein. J Biol Chem (1987) 1.86

First isolates of infectious human Borna disease virus from patients with mood disorders. Mol Psychiatry (1996) 1.83

Early and discrete changes in permeability of Escherichia coli and certain other gram-negative bacteria during killing by granulocytes. J Exp Med (1974) 1.82

Red-cell aggregation and red-cell deformability in diabetes. Diabetes (1976) 1.80

Endotoxin-neutralizing properties of the 25 kD N-terminal fragment and a newly isolated 30 kD C-terminal fragment of the 55-60 kD bactericidal/permeability-increasing protein of human neutrophils. J Exp Med (1991) 1.80

Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group. Leukemia (2012) 1.74

Prevention of pedestrian injuries to children: effectiveness of a school training program. Pediatrics (1991) 1.72

Intermittent dislocation flow in viscoplastic deformation. Nature (2001) 1.71

The role of lipopolysaccharides in the action of the bactericidal/permeability-increasing neutrophil protein on the bacterial envelope. J Immunol (1984) 1.67

Sequence conservation in field and experimental isolates of Borna disease virus. J Virol (1994) 1.67

Acceleration of wound healing by topical application of honey. An animal model. Am J Surg (1983) 1.66

Cellular and subcellular localization of the bactericidal/permeability-increasing protein of neutrophils. Blood (1987) 1.66

Detection of new DNA polymerase genes of known and potentially novel herpesviruses by PCR with degenerate and deoxyinosine-substituted primers. Virus Genes (1999) 1.65

Deletion of 13q14 remains an independent adverse prognostic variable in multiple myeloma despite its frequent detection by interphase fluorescence in situ hybridization. Blood (2000) 1.64

Source of bias in prenatal care utilization indices: implications for evaluating the Medicaid expansion. Am J Public Health (1991) 1.63

Amantadine and human Borna disease virus in vitro and in vivo in an infected patient with bipolar depression. Lancet (1997) 1.62

Pneumococcal septicemia in children with sickle cell anemia. Changing trend of survival. JAMA (1981) 1.62

Persistent, tolerant or subacute infection in Borna disease virus-infected rats. J Gen Virol (1983) 1.62

Cerebrovascular tone rather than intracranial pressure determines the effective downstream pressure of the cerebral circulation in the absence of intracranial hypertension. J Neurosurg Anesthesiol (2000) 1.61

Clp-mediated proteolysis in Gram-positive bacteria is autoregulated by the stability of a repressor. EMBO J (2001) 1.61

Heart rate variability. Frequency domain analysis. Cardiol Clin (1992) 1.60

Borna disease--neuropathology and pathogenesis. Curr Top Microbiol Immunol (1995) 1.59

Borna disease virus-specific antibodies in patients with HIV infection and with mental disorders. Lancet (1988) 1.57

Introduction of apoptosis by high proinsulin and glucose in cultured human umbilical vein endothelial cells is mediated by reactive oxygen species. Diabetologia (1998) 1.56

Low concentrations of indomethacin inhibit phospholipase A2 of rabbit polymorphonuclear leukocytes. Proc Natl Acad Sci U S A (1978) 1.56

The potent anti-Staphylococcus aureus activity of a sterile rabbit inflammatory fluid is due to a 14-kD phospholipase A2. J Clin Invest (1996) 1.54

The stress-free shape of the red blood cell membrane. Biophys J (1981) 1.53

Separation of sublethal and lethal effects of the bactericidal/permeability increasing protein on Escherichia coli. J Clin Invest (1990) 1.52

Oxygen-independent intracellular and oxygen-dependent extracellular killing of Escherichia coli S15 by human polymorphonuclear leukocytes. J Clin Invest (1985) 1.50

Antimicrobial peptides of phagocytes and epithelia. Semin Hematol (1997) 1.50

Influence of deformability of human red cells upon blood viscosity. Circ Res (1969) 1.49

Role of the bactericidal/permeability-increasing protein in host defence. Curr Opin Immunol (1998) 1.49

Antibacterial 15-kDa protein isoforms (p15s) are members of a novel family of leukocyte proteins. J Biol Chem (1993) 1.48

Environmental modulation of lipopolysaccharide chain length alters the sensitivity of Escherichia coli to the neutrophil bactericidal/permeability-increasing protein. Infect Immun (1986) 1.48

The bactericidal/permeability-increasing protein (BPI), a potent element in host-defense against gram-negative bacteria and lipopolysaccharide. Immunobiology (1993) 1.48

Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2013) 1.47

Erythropoiesis-stimulating agents in oncology: a study-level meta-analysis of survival and other safety outcomes. Br J Cancer (2010) 1.46

Preferential binding of the neutrophil cytoplasmic granule-derived bactericidal/permeability increasing protein to target bacteria. Implications and use as a means of purification. J Immunol (1989) 1.44

Selective block of urethral sphincter contraction using a modified Brindley electrode in sacral anterior root stimulation of the dog. Neurourol Urodyn (2002) 1.43

Isolation and characterization of a phospholipase A2 from an inflammatory exudate. J Lipid Res (1978) 1.42

Pathogenesis and treatment of renal failure in multiple myeloma. Leukemia (2008) 1.42

Bidirectional movement of a nascent polypeptide across microsomal membranes reveals requirements for vectorial translocation of proteins. Cell (1992) 1.41

Detection of fungi in tissue sections by lectin histochemistry. Arch Pathol Lab Med (1988) 1.41

Immunologic and genetic relationship between herpes simplex virus and bovine herpes mammillitis virus. Intervirology (1974) 1.41

Interferon-alpha treatment in multiple myeloma: meta-analysis of 30 randomised trials among 3948 patients. Ann Oncol (2000) 1.39

Reversible envelope effects during and after killing of Escherichia coli w by a highly-purified rabbit polymorpho-nuclear leukocyte fraction. Biochim Biophys Acta (1976) 1.39

Modeling of treatment response to erythropoiesis-stimulating agents as a function of center- and patient-related variables: results from the Anemia Cancer Treatment (ACT) study. Ann Oncol (2009) 1.39

[SAPHO syndrome. Case description of 3 patients with acne conglobata and osteoarticular symptoms]. Hautarzt (1997) 1.38

International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100). Leukemia (2009) 1.38

Specificity of cleavage in replicative-form DNA of bovine herpesvirus 1. J Virol (1988) 1.34

Borna disease in ostriches. Vet Rec (1993) 1.34

Individual and synergistic effects of rabbit granulocyte proteins on Escherichia coli. J Clin Invest (1994) 1.34

Carcinoma of the prostate gland: MR imaging with pelvic phased-array coils versus integrated endorectal--pelvic phased-array coils. Radiology (1994) 1.33

Shigella flexneri is trapped in polymorphonuclear leukocyte vacuoles and efficiently killed. Infect Immun (1997) 1.33

Efficacy of desmopressin in the treatment of nocturia: a double-blind placebo-controlled study in men. BJU Int (2002) 1.33

A tail electrode for unrestrained rats. J Exp Anal Behav (1967) 1.33

Morphine inhibits spontaneous and cytokine-enhanced natural killer cell cytotoxicity in volunteers. Anesthesiology (1995) 1.33

Purification of a cellular (granulocyte) and an extracellular (serum) phospholipase A2 that participate in the destruction of Escherichia coli in a rabbit inflammatory exudate. J Biol Chem (1990) 1.32

Studies on the relatedness of herpes viruses through DNA-RNA hybridization. Biochim Biophys Acta (1972) 1.31